immunocap feia  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 88

    Structured Review

    Thermo Fisher immunocap feia
    Evolution of Ig serum levels and IgG4 secreting cells in CG, RP and NRP. Ig levels in the different time points of the study were measured at the same time at the end of the first year of treatment. ( A ) Evolution of Total IgE (Ku/L). ( B ) Ratio between spIgE and spIgG4 in the three groups of patients represented as means and SD showing a significant decrease in RP from the first month of treatment. ( C ) Evolution of the percentage of IgG4 secreting cells determined by ELISpot and IgG4 serum levels determined by <t>ImmunoCAP-FEIA</t> in (C1) Controls, (C2) NRP and (C3) RP, where an increase of both parameters from the first month of AIT was observed. Statistical Wilcoxon and Mann-Whitney U tests were performed. The Bonferroni correction was applied for comparison of three groups and five different time points.
    Immunocap Feia, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 6 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunocap feia/product/Thermo Fisher
    Average 88 stars, based on 6 article reviews
    Price from $9.99 to $1999.99
    immunocap feia - by Bioz Stars, 2020-07
    88/100 stars

    Images

    1) Product Images from "Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response"

    Article Title: Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response

    Journal: Scientific Reports

    doi: 10.1038/srep14482

    Evolution of Ig serum levels and IgG4 secreting cells in CG, RP and NRP. Ig levels in the different time points of the study were measured at the same time at the end of the first year of treatment. ( A ) Evolution of Total IgE (Ku/L). ( B ) Ratio between spIgE and spIgG4 in the three groups of patients represented as means and SD showing a significant decrease in RP from the first month of treatment. ( C ) Evolution of the percentage of IgG4 secreting cells determined by ELISpot and IgG4 serum levels determined by ImmunoCAP-FEIA in (C1) Controls, (C2) NRP and (C3) RP, where an increase of both parameters from the first month of AIT was observed. Statistical Wilcoxon and Mann-Whitney U tests were performed. The Bonferroni correction was applied for comparison of three groups and five different time points.
    Figure Legend Snippet: Evolution of Ig serum levels and IgG4 secreting cells in CG, RP and NRP. Ig levels in the different time points of the study were measured at the same time at the end of the first year of treatment. ( A ) Evolution of Total IgE (Ku/L). ( B ) Ratio between spIgE and spIgG4 in the three groups of patients represented as means and SD showing a significant decrease in RP from the first month of treatment. ( C ) Evolution of the percentage of IgG4 secreting cells determined by ELISpot and IgG4 serum levels determined by ImmunoCAP-FEIA in (C1) Controls, (C2) NRP and (C3) RP, where an increase of both parameters from the first month of AIT was observed. Statistical Wilcoxon and Mann-Whitney U tests were performed. The Bonferroni correction was applied for comparison of three groups and five different time points.

    Techniques Used: Enzyme-linked Immunospot, MANN-WHITNEY

    Related Articles

    other:

    Article Title: Dermatophagoides pteronyssinus immunotherapy changes the T-regulatory cell activity
    Article Snippet: Specific IgE and IgG4 determination Levels of sIgE and sIgG4 to DP (d1) were determined by ImmunoCAP-FEIA in serum samples, according to the manufacturer’s instructions (Thermo Fisher Scientific, Massachusetts, USA).

    Article Title: Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response
    Article Snippet: Total and specific IgE, IgG4 assays Total and specific IgE and IgG4 to DP were determined by ImmunoCAP-FEIA in serum samples, according to manufacturer instructions (Thermo Fisher Scientific, Massachusetts, USA).

    Article Title: Safety and feasibility of oral immunotherapy to multiple allergens for food allergy
    Article Snippet: Serological analysis Sera at baseline and at 12 months were analyzed for food-specific IgE and IgG4 levels by immunoCAP FEIA (Thermofisher Scientific/Phadia, Kalmazoo, MI) when available.

    Similar Products

  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 88
    Thermo Fisher immunocap feia
    Evolution of Ig serum levels and IgG4 secreting cells in CG, RP and NRP. Ig levels in the different time points of the study were measured at the same time at the end of the first year of treatment. ( A ) Evolution of Total IgE (Ku/L). ( B ) Ratio between spIgE and spIgG4 in the three groups of patients represented as means and SD showing a significant decrease in RP from the first month of treatment. ( C ) Evolution of the percentage of IgG4 secreting cells determined by ELISpot and IgG4 serum levels determined by <t>ImmunoCAP-FEIA</t> in (C1) Controls, (C2) NRP and (C3) RP, where an increase of both parameters from the first month of AIT was observed. Statistical Wilcoxon and Mann-Whitney U tests were performed. The Bonferroni correction was applied for comparison of three groups and five different time points.
    Immunocap Feia, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 8 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/immunocap feia/product/Thermo Fisher
    Average 88 stars, based on 8 article reviews
    Price from $9.99 to $1999.99
    immunocap feia - by Bioz Stars, 2020-07
    88/100 stars
      Buy from Supplier

    Image Search Results


    Evolution of Ig serum levels and IgG4 secreting cells in CG, RP and NRP. Ig levels in the different time points of the study were measured at the same time at the end of the first year of treatment. ( A ) Evolution of Total IgE (Ku/L). ( B ) Ratio between spIgE and spIgG4 in the three groups of patients represented as means and SD showing a significant decrease in RP from the first month of treatment. ( C ) Evolution of the percentage of IgG4 secreting cells determined by ELISpot and IgG4 serum levels determined by ImmunoCAP-FEIA in (C1) Controls, (C2) NRP and (C3) RP, where an increase of both parameters from the first month of AIT was observed. Statistical Wilcoxon and Mann-Whitney U tests were performed. The Bonferroni correction was applied for comparison of three groups and five different time points.

    Journal: Scientific Reports

    Article Title: Differential Plasma-cell evolution is linked with Dermatophagoides pteronyssinus immunotherapy response

    doi: 10.1038/srep14482

    Figure Lengend Snippet: Evolution of Ig serum levels and IgG4 secreting cells in CG, RP and NRP. Ig levels in the different time points of the study were measured at the same time at the end of the first year of treatment. ( A ) Evolution of Total IgE (Ku/L). ( B ) Ratio between spIgE and spIgG4 in the three groups of patients represented as means and SD showing a significant decrease in RP from the first month of treatment. ( C ) Evolution of the percentage of IgG4 secreting cells determined by ELISpot and IgG4 serum levels determined by ImmunoCAP-FEIA in (C1) Controls, (C2) NRP and (C3) RP, where an increase of both parameters from the first month of AIT was observed. Statistical Wilcoxon and Mann-Whitney U tests were performed. The Bonferroni correction was applied for comparison of three groups and five different time points.

    Article Snippet: Total and specific IgE, IgG4 assays Total and specific IgE and IgG4 to DP were determined by ImmunoCAP-FEIA in serum samples, according to manufacturer instructions (Thermo Fisher Scientific, Massachusetts, USA).

    Techniques: Enzyme-linked Immunospot, MANN-WHITNEY